India's Sun Pharmaceutical Industries Ltd has received a tentative approval from the US Food and Drug Administration for rivastigmine capsules, a drug for Alzheimer's, the agency said in a statement.
{{^htLoading}} {{/htLoading}}
Sun shares rose 0.9 per cent to Rs 874 in a firm Mumbai market
Check India news real-time updates, latest news on Hindustan Times and more across India.
Advertisement
{{/htLoading}}{{#usCountry}}